0001231919-26-000338.txt : 20260414 0001231919-26-000338.hdr.sgml : 20260414 20260414144037 ACCESSION NUMBER: 0001231919-26-000338 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260414 DATE AS OF CHANGE: 20260414 EFFECTIVENESS DATE: 20260414 FILER: COMPANY DATA: COMPANY CONFORMED NAME: REFRAME HEALTH, INC. CENTRAL INDEX KEY: 0001966671 ORGANIZATION NAME: EIN: 872348633 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-580363 FILM NUMBER: 26860472 BUSINESS ADDRESS: STREET 1: 447 SUTTER ST, STE 405 PMB 247 CITY: SAN FRANCISCO STATE: CA ZIP: 94108 BUSINESS PHONE: 980-785-3775 MAIL ADDRESS: STREET 1: 447 SUTTER ST, STE 405 PMB 247 CITY: SAN FRANCISCO STATE: CA ZIP: 94108 D 1 primary_doc.xml X0708 D LIVE 0001966671 REFRAME HEALTH, INC. c/o Reframe Health, Inc. 447 SUTTER ST, STE 405 #247 SAN FRANCISCO CA CALIFORNIA 94108 415-275-2574 DELAWARE None None Corporation true 2021 Jessica Leigh Bell 447 Sutter St, Ste 405 #247 San Francisco CA CALIFORNIA 94108 Executive Officer Director Cornelis Edward Johannes van der Wal c/o Reframe Health, Inc. 447 Sutter St, Ste 405 PMB 247 San Francisco CA CALIFORNIA 94108 Executive Officer Director Andrew Mitchell c/o Reframe Health, Inc. 447 Sutter St, Ste 405 PMB 247 San Francisco CA CALIFORNIA 94108 Director Other Decline to Disclose 06b false 2025-12-05 false true true Sale and issuance of Series Seed-2 and Series Seed-3 Preferred Stock ("Series Seed") and the underlying shares of Common Stock issuable upon conversion of Series Seed. false 0 4714701 4306883 407818 false 25 0 0 0 false REFRAME HEALTH, INC. /s/ Jessica Leigh Bell Jessica Leigh Bell Chief Executive Officer 2026-04-12